Immuron ceo, steven lydeamore investor webinar presentation

Melbourne, australia, nov. 28, 2023 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company is pleased to invite shareholders to attend an investor webinar “coffee microcaps morning meeting”, to be held on thursday, 30th of november, 2023, 9:00am adest.
IMRN Ratings Summary
IMRN Quant Ranking